ABBV vs CHE · P/E 81, rev $61.16B vs P/E 24, rev $2.43B
AbbVie Inc (ABBV) versus Chemed Corp (CHE) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Not investment advice. Open the ABBV and CHE stock pages for the full models.
Not investment advice.